OLVIG
MBIO icon

Oliver Lagore Vanvalin Investment Group’s Mustang Bio MBIO Stock Holding History

Oliver Lagore Vanvalin Investment Group’s Portfolio MBIO Stock Details MBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Hold
0
– -$12 – 795
2023
Q4 		– Hold
0
– – – 759
2023
Q3 		– Sell
-1
Closed -$194 – 835
2023
Q2 		$366 Hold
1
– – ﹤0.01% 733
2023
Q1 		$326 Hold
1
– – ﹤0.01% 666
2022
Q4 		$351 Hold
1
– – ﹤0.01% 627
2022
Q3 		$0 Hold
1
– – ﹤0.01% 690
2022
Q2 		$1K Hold
1
– – ﹤0.01% 568
2022
Q1 		$1K Buy
+1
New +$822 ﹤0.01% 539

Other funds holding MBIO

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Oliver Lagore Vanvalin Investment Group's MBIO Position: Q1 2024 in Review

Oliver Lagore Vanvalin Investment Group held its Mustang Bio (MBIO) position steady in Q1 2024 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #795.

Oliver Lagore Vanvalin Investment Group first reported a position in MBIO in Q1 2022 and has held it in 6 quarters since. The position peaked at $1K in Q2 2022. 27 funds tracked by Wall St. Rank hold MBIO as of Q1 2024.

  • Oliver Lagore Vanvalin Investment Group held 0 shares of Mustang Bio worth $0 as of Q1 2024.
  • Oliver Lagore Vanvalin Investment Group left its Mustang Bio share count unchanged in Q1 2024.
  • Mustang Bio made up ﹤0.01% of Oliver Lagore Vanvalin Investment Group's portfolio in Q1 2024, its #795 holding.
  • Oliver Lagore Vanvalin Investment Group first reported a position in Mustang Bio in Q1 2022 and has held it in 6 quarters since.
  • Oliver Lagore Vanvalin Investment Group's Mustang Bio position peaked at $1K in Q2 2022.
  • 27 funds tracked by Wall St. Rank held Mustang Bio as of Q1 2024.

Based on Oliver Lagore Vanvalin Investment Group's 13F filing for Q1 2024, filed 15 May 2024.